Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | FOR SOLUTION;ORAL | 10GM | 1 | PIZENSY | LACTITOL |
002 | SOLUTION;ORAL | 20G | 2 | PIZENSY | LACTITOL |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2020-02-12 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
BRAINTREE LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 211281
[companyName] => BRAINTREE LABS
[docInserts] => ["",""]
[products] => [{"drugName":"PIZENSY","activeIngredients":"LACTITOL","strength":"10GM","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"PIZENSY","activeIngredients":"LACTITOL","strength":"20G","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"02\/12\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/211281s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"02\/12\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/211281s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/211281Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2020\\\/211281Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2020-02-12
)
)